- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00365118
Treatment of Naevus Flammeus Using Intense Pulsed Light and Pulsed Dye Laser
June 2, 2008 updated by: Bispebjerg Hospital
The purpose of the trial is to compare efficacy and adverse effects of pulsed dye laser and intense pulsed light in patients with port wine stains.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Copenhagen nv
-
Copenhagen, Copenhagen nv, Denmark, 2400
- Bispebjerg Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with previously untreated and previously laser-treated naevus flammeus. Naevus flammeus measuring at least 5 x 7 cm within a single anatomical area. For example, the face corresponding to dermatomes V1, V2 and V3, back, abdomen, arms and legs.Patients aged two or above.Patients with skin types I-III.
Exclusion Criteria:
- Patients below two years of age.
- Pregnant or breastfeeding patients.
- Patients with known increased sensitivity to visible light.
- Patients with a tendency to produce hypertrophic scars or celoids.
- Patients with skin types IV, V and VI.
- Patients who are clearly pigmented following recent exposure to the sun or a solarium.
- Patients treated with Roaccutane during the last six months.
- Patients who are not considered able to follow the treatment protocol (e.g. severely alcoholic patients, dementia patients, mentally ill patients, etc.).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: SINGLE
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2005
Primary Completion (ACTUAL)
December 1, 2007
Study Completion (ACTUAL)
December 1, 2007
Study Registration Dates
First Submitted
August 15, 2006
First Submitted That Met QC Criteria
August 16, 2006
First Posted (ESTIMATE)
August 17, 2006
Study Record Updates
Last Update Posted (ESTIMATE)
June 3, 2008
Last Update Submitted That Met QC Criteria
June 2, 2008
Last Verified
June 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KF-01-278867
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Port-Wine Stain
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...CompletedPort-wine StainChina
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedPort-wine StainUnited States
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedPORT WINE STAINUnited States
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Completed
-
Centre Hospitalier Universitaire de NiceCompletedPort-wine StainsFrance
-
University of Lausanne HospitalsUnknownPort-wine Stains (PWS)
-
Henry VasconezGraceway Pharmaceuticals, LLCTerminated
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedPort Wine StainsUnited States
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Not yet recruitingPort-Wine Stain | Nevus Flammeus | Port-wine Birthmark
Clinical Trials on Pulsed dye laser (Candela), Intense pulsed light (Palomar)
-
Xijing HospitalCompleted
-
Bispebjerg HospitalUnknownPulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin RednessErythema | TelangiectasisDenmark
-
Bispebjerg HospitalTerminated
-
University of California, IrvineBeckman Laser Institute University of California Irvine; Candela CorporationCompleted
-
Nick van der BeekAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Active, not recruitingPsoriasis VulgarisNetherlands
-
University of Nove de JulhoNot yet recruiting
-
NHS Greater Glasgow and ClydeUnknown
-
Goldman, Butterwick, Fitzpatrick and GroffNot yet recruitingKeratosis Pilaris
-
Bispebjerg HospitalCompleted
-
Toyos ClinicCompleted